Disruption of the dopamine D2 receptor impairs insulin secretion and causes glucose intolerance
The relationship between antidopaminergic drugs and glucose has not been extensively studied, even though chronic neuroleptic treatment causes hyperinsulinemia in normal subjects or is associated with diabetes in psychiatric patients. We sought to evaluate dopamine D2 receptor (D2R) participation in...
Guardado en:
Autores principales: | , , |
---|---|
Publicado: |
2010
|
Materias: | |
Acceso en línea: | https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00137227_v151_n4_p1441_GarciaTornadu http://hdl.handle.net/20.500.12110/paper_00137227_v151_n4_p1441_GarciaTornadu |
Aporte de: |
id |
paper:paper_00137227_v151_n4_p1441_GarciaTornadu |
---|---|
record_format |
dspace |
spelling |
paper:paper_00137227_v151_n4_p1441_GarciaTornadu2023-06-08T14:36:15Z Disruption of the dopamine D2 receptor impairs insulin secretion and causes glucose intolerance García Tornadú, Isabel Andrea Chamson, Astrid de Reig Rubinstein, Marcelo cabergoline dopamine 2 receptor haloperidol animal cell animal experiment animal model animal tissue article cell division cell isolation drug mechanism glucose homeostasis glucose intolerance immunohistochemistry in vitro study in vivo study insulin release insulin tolerance test male mouse nonhuman pancreas function pancreas islet beta cell pancreas islet cell priority journal Analysis of Variance Animals Blood Glucose Cell Proliferation Dopamine Agonists Dopamine Antagonists Ergolines Female Glucose Glucose Intolerance Haloperidol Immunohistochemistry Insulin Insulin-Like Growth Factor I Male Mice Mice, Knockout Pancreas Prolactin Radioimmunoassay Receptors, Dopamine D2 Time Factors The relationship between antidopaminergic drugs and glucose has not been extensively studied, even though chronic neuroleptic treatment causes hyperinsulinemia in normal subjects or is associated with diabetes in psychiatric patients. We sought to evaluate dopamine D2 receptor (D2R) participation in pancreatic function. Glucose homeostasis was studied in D2R knockout mice (Drd2-/-) mice and in isolated islets from wild-type and Drd2-/- mice, using different pharmacological tools. Pancreas immunohistochemistry was performed. Drd2-/- male mice exhibited an impairment of insulin response to glucose and high fasting glucose levels and were glucose intolerant. Glucose intolerance resulted from a blunted insulin secretory response, rather than insulin resistance, as shown by glucose-stimulated insulin secretion tests (GSIS) in vivo and in vitro and by a conserved insulin tolerance test in vivo. On the other hand, short-term treatment with cabergoline, a dopamine agonist, resulted in glucose intolerance and decreased insulin response to glucose in wild-type but not in Drd2 -/- mice; this effect was partially prevented by haloperidol, a D2R antagonist. In vitro results indicated that GSIS was impaired in islets from Drd2-/- mice and that only in wild-type islets did dopamine inhibit GSIS, an effect that was blocked by a D2R but not a D1R antagonist. Finally, immunohistochemistry showed a diminished pancreatic β-cell mass in Drd2-/-mice and decreasedβ-cell replication in 2-month-old Drd2-/- mice. Pancreatic D2Rs inhibit glucose-stimulated insulin release. Lack of dopaminergic inhibition throughout development may exert a gradual deteriorating effect on insulin homeostasis, so that eventually glucose intolerance develops. Copyright © 2010 by The Endocrine Society. Fil:García-Tornadú, I. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Chamson-Reig, A. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Rubinstein, M. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. 2010 https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00137227_v151_n4_p1441_GarciaTornadu http://hdl.handle.net/20.500.12110/paper_00137227_v151_n4_p1441_GarciaTornadu |
institution |
Universidad de Buenos Aires |
institution_str |
I-28 |
repository_str |
R-134 |
collection |
Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA) |
topic |
cabergoline dopamine 2 receptor haloperidol animal cell animal experiment animal model animal tissue article cell division cell isolation drug mechanism glucose homeostasis glucose intolerance immunohistochemistry in vitro study in vivo study insulin release insulin tolerance test male mouse nonhuman pancreas function pancreas islet beta cell pancreas islet cell priority journal Analysis of Variance Animals Blood Glucose Cell Proliferation Dopamine Agonists Dopamine Antagonists Ergolines Female Glucose Glucose Intolerance Haloperidol Immunohistochemistry Insulin Insulin-Like Growth Factor I Male Mice Mice, Knockout Pancreas Prolactin Radioimmunoassay Receptors, Dopamine D2 Time Factors |
spellingShingle |
cabergoline dopamine 2 receptor haloperidol animal cell animal experiment animal model animal tissue article cell division cell isolation drug mechanism glucose homeostasis glucose intolerance immunohistochemistry in vitro study in vivo study insulin release insulin tolerance test male mouse nonhuman pancreas function pancreas islet beta cell pancreas islet cell priority journal Analysis of Variance Animals Blood Glucose Cell Proliferation Dopamine Agonists Dopamine Antagonists Ergolines Female Glucose Glucose Intolerance Haloperidol Immunohistochemistry Insulin Insulin-Like Growth Factor I Male Mice Mice, Knockout Pancreas Prolactin Radioimmunoassay Receptors, Dopamine D2 Time Factors García Tornadú, Isabel Andrea Chamson, Astrid de Reig Rubinstein, Marcelo Disruption of the dopamine D2 receptor impairs insulin secretion and causes glucose intolerance |
topic_facet |
cabergoline dopamine 2 receptor haloperidol animal cell animal experiment animal model animal tissue article cell division cell isolation drug mechanism glucose homeostasis glucose intolerance immunohistochemistry in vitro study in vivo study insulin release insulin tolerance test male mouse nonhuman pancreas function pancreas islet beta cell pancreas islet cell priority journal Analysis of Variance Animals Blood Glucose Cell Proliferation Dopamine Agonists Dopamine Antagonists Ergolines Female Glucose Glucose Intolerance Haloperidol Immunohistochemistry Insulin Insulin-Like Growth Factor I Male Mice Mice, Knockout Pancreas Prolactin Radioimmunoassay Receptors, Dopamine D2 Time Factors |
description |
The relationship between antidopaminergic drugs and glucose has not been extensively studied, even though chronic neuroleptic treatment causes hyperinsulinemia in normal subjects or is associated with diabetes in psychiatric patients. We sought to evaluate dopamine D2 receptor (D2R) participation in pancreatic function. Glucose homeostasis was studied in D2R knockout mice (Drd2-/-) mice and in isolated islets from wild-type and Drd2-/- mice, using different pharmacological tools. Pancreas immunohistochemistry was performed. Drd2-/- male mice exhibited an impairment of insulin response to glucose and high fasting glucose levels and were glucose intolerant. Glucose intolerance resulted from a blunted insulin secretory response, rather than insulin resistance, as shown by glucose-stimulated insulin secretion tests (GSIS) in vivo and in vitro and by a conserved insulin tolerance test in vivo. On the other hand, short-term treatment with cabergoline, a dopamine agonist, resulted in glucose intolerance and decreased insulin response to glucose in wild-type but not in Drd2 -/- mice; this effect was partially prevented by haloperidol, a D2R antagonist. In vitro results indicated that GSIS was impaired in islets from Drd2-/- mice and that only in wild-type islets did dopamine inhibit GSIS, an effect that was blocked by a D2R but not a D1R antagonist. Finally, immunohistochemistry showed a diminished pancreatic β-cell mass in Drd2-/-mice and decreasedβ-cell replication in 2-month-old Drd2-/- mice. Pancreatic D2Rs inhibit glucose-stimulated insulin release. Lack of dopaminergic inhibition throughout development may exert a gradual deteriorating effect on insulin homeostasis, so that eventually glucose intolerance develops. Copyright © 2010 by The Endocrine Society. |
author |
García Tornadú, Isabel Andrea Chamson, Astrid de Reig Rubinstein, Marcelo |
author_facet |
García Tornadú, Isabel Andrea Chamson, Astrid de Reig Rubinstein, Marcelo |
author_sort |
García Tornadú, Isabel Andrea |
title |
Disruption of the dopamine D2 receptor impairs insulin secretion and causes glucose intolerance |
title_short |
Disruption of the dopamine D2 receptor impairs insulin secretion and causes glucose intolerance |
title_full |
Disruption of the dopamine D2 receptor impairs insulin secretion and causes glucose intolerance |
title_fullStr |
Disruption of the dopamine D2 receptor impairs insulin secretion and causes glucose intolerance |
title_full_unstemmed |
Disruption of the dopamine D2 receptor impairs insulin secretion and causes glucose intolerance |
title_sort |
disruption of the dopamine d2 receptor impairs insulin secretion and causes glucose intolerance |
publishDate |
2010 |
url |
https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00137227_v151_n4_p1441_GarciaTornadu http://hdl.handle.net/20.500.12110/paper_00137227_v151_n4_p1441_GarciaTornadu |
work_keys_str_mv |
AT garciatornaduisabelandrea disruptionofthedopamined2receptorimpairsinsulinsecretionandcausesglucoseintolerance AT chamsonastriddereig disruptionofthedopamined2receptorimpairsinsulinsecretionandcausesglucoseintolerance AT rubinsteinmarcelo disruptionofthedopamined2receptorimpairsinsulinsecretionandcausesglucoseintolerance |
_version_ |
1768544302640660480 |